Literature DB >> 32248632

Corrected human papillomavirus vaccination rates for each birth fiscal year in Japan.

Satoshi Nakagawa1, Yutaka Ueda1, Asami Yagi1, Sayaka Ikeda2, Kosuke Hiramatsu1, Tadashi Kimura1.   

Abstract

In Japan, the serious adverse events after human papillomavirus (HPV) vaccination were widely reported in the media. The Ministry of Health, Labour and Welfare of Japan (MHLW) announced the suspension of the governmental recommendation of HPV vaccine in 2013, and the inoculation rate has since sharply declined. The estimated inoculation rate for each birth fiscal year (FY) announced by the MHLW and the actual numbers for each birth FY surveyed by local governments were very different. In particular, the cumulative vaccination rate of girls born in FY2000 was regarded to be as high as 42.9% by the Council of the MHLW. However, this estimation included a confusion. When the suspension of the governmental recommendation was announced in FY2013, the girls born in FY2000 turned 13 years old, the targeted starting age of the HPV vaccination. The vaccination rate of this generation is considered to be quite low. The numbers were recalculated in this study. This study revealed that the real vaccination rate is only 14.3%. Female individuals born in or after FY2000 have been confirmed to be exposed to the same cervical cancer risk as before the HPV vaccine was introduced in Japan.
© 2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.

Entities:  

Keywords:  Japan; fiscal year; governmental suspension of recommendation; vaccination rate; vaccine

Year:  2020        PMID: 32248632     DOI: 10.1111/cas.14406

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  12 in total

1.  Effect of Different Educational Interventions on Knowledge of HPV Vaccination and Cervical Cancer among Young Women: A Preliminary Report.

Authors:  Yuko Takahashi; Haruka Nishida; Takayuki Ichinose; Yuko Miyagawa; Koichiro Kido; Haruko Hiraike; Hirono Ishikawa; Kazunori Nagasaka
Journal:  Int J Environ Res Public Health       Date:  2022-04-25       Impact factor: 4.614

2.  A potential means to help the HPV vaccine penetrate the Japanese public while under the continued suspension of governmental recommendation.

Authors:  Natsuyo Ugumori; Yutaka Ueda; Asami Yagi; Hazuki Abe; Mayu Shiomi; Satoshi Nakagawa; Kosuke Hiramatsu; Ai Miyoshi; Eiji Kobayashi; Toshihiro Kimura; Tadashi Kimura; Motowo Nabeta
Journal:  Hum Vaccin Immunother       Date:  2021-04-20       Impact factor: 3.452

3.  Health consciousness and cervical cancer screening rates in HPV-unvaccinated girls: comparison from HPV-recommended and HPV-recommendation-suspended program periods.

Authors:  Ai Miyoshi; Yutaka Ueda; Asami Yagi; Mariko Taniguchi; Masayuki Sekine; Takayuki Enomoto; Tadashi Kimura
Journal:  Hum Vaccin Immunother       Date:  2020-12-03       Impact factor: 3.452

4.  Internet Survey of Awareness and Behavior Related to HPV Vaccination in Japan.

Authors:  Risa Kudo; Masayuki Sekine; Manako Yamaguchi; Megumi Hara; Sharon J B Hanley; Yutaka Ueda; Asami Yagi; Sosuke Adachi; Megumi Kurosawa; Etsuko Miyagi; Takayuki Enomoto
Journal:  Vaccines (Basel)       Date:  2021-01-25

5.  The looming health hazard: A wave of HPV-related cancers in Japan is becoming a reality due to the continued suspension of the governmental recommendation of HPV vaccine.

Authors:  Asami Yagi; Yutaka Ueda; Sayaka Ikeda; Etsuko Miyagi; Masayuki Sekine; Takayuki Enomoto; Tadashi Kimura
Journal:  Lancet Reg Health West Pac       Date:  2021-12-13

6.  The 'best friend effect': a promising tool to encourage HPV vaccination in Japan.

Authors:  Asami Yagi; Yutaka Ueda; Yoshimi Tomine; Sayaka Ikeda; Mamoru Kakuda; Satoshi Nakagawa; Kosuke Hiramatsu; Ai Miyoshi; Eiji Kobayashi; Toshihiro Kimura; Kei Hirai; Tadashi Kimura
Journal:  Int J Clin Oncol       Date:  2022-09-03       Impact factor: 3.850

7.  The last strategy for re-dissemination of HPV vaccination in Japan while still under the suspension of the governmental recommendation.

Authors:  Yutaka Ueda; Asami Yagi; Hazuki Abe; Satoshi Nakagawa; Ryoko Minekawa; Haruo Kuroki; Ayako Miwa; Tadashi Kimura
Journal:  Sci Rep       Date:  2020-09-30       Impact factor: 4.379

8.  Potential for cervical cancer incidence and death resulting from Japan's current policy of prolonged suspension of its governmental recommendation of the HPV vaccine.

Authors:  Asami Yagi; Yutaka Ueda; Satoshi Nakagawa; Sayaka Ikeda; Yusuke Tanaka; Masayuki Sekine; Etsuko Miyagi; Takayuki Enomoto; Tadashi Kimura
Journal:  Sci Rep       Date:  2020-09-29       Impact factor: 4.379

9.  Current status of cervical cytology during pregnancy in Japan.

Authors:  Shunji Suzuki; Eijiro Hayata; Shin-Ichi Hoshi; Akihiko Sekizawa; Yoko Sagara; Masanobu Tanaka; Katsuyuki Kinoshita; Tadaichi Kitamura
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.752

10.  Long-term effectiveness of HPV vaccination against HPV infection in young Japanese women: Real-world data.

Authors:  Megumi Kurosawa; Masayuki Sekine; Manako Yamaguchi; Risa Kudo; Sharon J B Hanley; Megumi Hara; Sosuke Adachi; Yutaka Ueda; Etsuko Miyagi; Sayaka Ikeda; Asami Yagi; Takayuki Enomoto
Journal:  Cancer Sci       Date:  2022-02-14       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.